
NeuroBioTex Inc Profile last edited on: 12/14/2023
CAGE: 4CVU6
UEI: J5SGWMMHPAH8
Business Identifier: Zinc-Based Diagnostics and Research Tools Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
101 Christopher Columbus Boulevard
Galveston, TX 77550
Galveston, TX 77550
(409) 762-0678 |
c.j.frederickson@neurobiotex.com |
www.neurobiotex.com |
Location: Single
Congr. District: 14
County: Galveston
Congr. District: 14
County: Galveston
Public Profile
NeuroBioTex, Inc. is a medical research and technology development firm specializing in matters pertaining to zinc and health, with particular emphasis on the roles of zinc in normal and abnormal brain function. The firm develops research tools, diagnostics, and therapeutics for diseases involving zinc. The company focuses on ionic zinc signals, including the cells that secrete them, the channels through which they travel, and the receptors that are tuned to the zinc signals. It also develops diagnostic and therapeutic tools for the clinician to diagnose and treat disorders stemming from disturbances of the concentrations of free zinc in organisms or tissues. The companys products include low zinc reagents, precise free zinc measurement instruments, zinc traps, zinc stains and probes, and zinc-buffers and media.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2018 | 2 | NIH | $1,529,197 | |
Project Title: Portable Instrument for Assessing Zinc Deficiency in Children and the Elderly | ||||
2010 | 2 | NIH | $1,263,887 | |
Project Title: Zinc-Based Diagnostic for Prostate Cancer | ||||
2006 | 2 | NIH | $1,062,233 | |
Project Title: Zinc Sensors for Neurology and Neuroscience | ||||
2006 | 1 | NIH | $338,500 | |
Project Title: Flourescent Tools for the Study of Metallothionein | ||||
2004 | 2 | NIH | $606,335 | |
Project Title: High-Speed Microfluidic Sorting of Biohazardous Cells |
Key People / Management
Christopher J Frederickson -- CEO & CTO
Cathleen Frederickson -- Owner
Leo Giblin
Cathleen Frederickson -- Owner
Leo Giblin